Literature DB >> 8612134

Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice.

M R Hodge1, A M Ranger, F Charles de la Brousse, T Hoey, M J Grusby, L H Glimcher.   

Abstract

NF-ATp is a member of a family of genes that encodes the cytoplasmic component of the nuclear factor of activated T cells (NF-AT). In this study, we show that mice with a null mutation in the NF-ATp gene have splenomegaly with hyperproliferation of both B and T cells. They also display early defects in the transcription of multiple genes encoding cytokines and cell surface receptors, including CD40L and FasL. A striking defect in early IL-4 production was observed after ligation of the TCR complex by treatment with anti-CD3 in vivo. The transcription of other cytokines including IL-13, GM-CSF, and TNF alpha was also affected, though to a lesser degree. Interestingly, the cytokines IL-2 and IFN gamma were minimally affected. Despite this early defect in IL-4 transcription, Th2 development was actually enhanced at later timepoints as evidenced by increased IL-4 production and IgE levels in situations that favor the formation of Th2 cells both in vitro and in vivo. These data suggest that NF-ATp may be involved in cell growth, and that it is important for the balanced transcription of the IL-4 gene during the course of an immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612134     DOI: 10.1016/s1074-7613(00)80253-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  134 in total

1.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun.

Authors:  C Lopez-Rodríguez; J Aramburu; A S Rakeman; A Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

4.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 5.  Transcriptional control of thymocyte positive selection.

Authors:  Gilbert J Kersh
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

7.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

8.  Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.

Authors:  S Martínez-Martínez; P Gómez del Arco; A L Armesilla; J Aramburu; C Luo; A Rao; J M Redondo
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  Function of the nucleotide exchange activity of vav1 in T cell development and activation.

Authors:  Alexander Saveliev; Lesley Vanes; Olga Ksionda; Jonathan Rapley; Stephen J Smerdon; Katrin Rittinger; Victor L J Tybulewicz
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

Review 10.  SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells.

Authors:  Stéphane Bécart; Amnon Altman
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.